Literature DB >> 8538623

Protein kinase D (PKD): a novel target for diacylglycerol and phorbol esters.

E Rozengurt1, J Sinnett-Smith, J Van Lint, A M Valverde.   

Abstract

A novel serine/threonine protein kinase regulated by phorbol esters and diacylglycerol (named PKD) has been identified. PKD contains a cysteine-rich repeat sequence homologous to that seen in the regulatory domain of protein kinase C (PKC). A bacterially expressed NH2-terminal domain of PKD exhibited high affinity phorbol ester binding activity (Kd = 35 nM). Expression of PKD cDNA in COS cells conferred increased phorbol ester binding to intact cells. The catalytic domain of PKD contains all characteristic sequence motifs of serine protein kinases but shows only a low degree of sequence similarity to PKCs. The bacterially expressed catalytic domain of PKD efficiently phosphorylated the exogenous peptide substrate syntide-2 in serine but did not catalyse significant phosphorylation of a variety of other substrates utilised by PKCs and other major second messenger regulated kinases. PKD expressed in COS cells showed syntide-2 kinase activity that was stimulated by phorbol esters in the presence of phospholipids. We propose that PKD may be a novel component in the transduction of diacylglycerol and phorbol ester signals.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8538623     DOI: 10.1016/0027-5107(95)00141-7

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  16 in total

1.  Involvement of protein kinase D in Fc gamma-receptor activation of the NADPH oxidase in neutrophils.

Authors:  Jan K Davidson-Moncada; Guillermo Lopez-Lluch; Anthony W Segal; Lodewijk V Dekker
Journal:  Biochem J       Date:  2002-04-01       Impact factor: 3.857

Review 2.  Role of protein kinase D signaling in pancreatic cancer.

Authors:  Sushovan Guha; Suebpong Tanasanvimon; James Sinnett-Smith; Enrique Rozengurt
Journal:  Biochem Pharmacol       Date:  2010-07-16       Impact factor: 5.858

3.  Co-transfection with protein kinase D confers phorbol-ester-mediated inhibition on glucagon-stimulated cAMP accumulation in COS cells transfected to overexpress glucagon receptors.

Authors:  E S Tobias; E Rozengurt; J M Connell; M D Houslay
Journal:  Biochem J       Date:  1997-09-01       Impact factor: 3.857

4.  A novel protein kinase D inhibitor attenuates early events of experimental pancreatitis in isolated rat acini.

Authors:  Edwin C Thrower; Jingzhen Yuan; Ashar Usmani; Yannan Liu; Courtney Jones; Samantha N Minervini; Martine Alexandre; Stephen J Pandol; Sushovan Guha
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-10-14       Impact factor: 4.052

5.  Protein kinase D (PKD) activation in intact cells through a protein kinase C-dependent signal transduction pathway.

Authors:  J L Zugaza; J Sinnett-Smith; J Van Lint; E Rozengurt
Journal:  EMBO J       Date:  1996-11-15       Impact factor: 11.598

6.  Overcoming amino-Nogo-induced inhibition of cell spreading and neurite outgrowth by 12-O-tetradecanoylphorbol-13-acetate-type tumor promoters.

Authors:  Kangwen Deng; Ying Gao; Zixuan Cao; Edmund I Graziani; Andrew Wood; Patrick Doherty; Frank S Walsh
Journal:  J Biol Chem       Date:  2009-12-15       Impact factor: 5.157

7.  Induced overexpression of protein kinase D1 stimulates mitogenic signaling in human pancreatic carcinoma PANC-1 cells.

Authors:  Krisztina Kisfalvi; Cliff Hurd; Sushovan Guha; Enrique Rozengurt
Journal:  J Cell Physiol       Date:  2010-05       Impact factor: 6.384

8.  Protein kinase d regulates trafficking of dendritic membrane proteins in developing neurons.

Authors:  Mariano Bisbal; Cecilia Conde; Maribel Donoso; Flavia Bollati; Juliana Sesma; Santiago Quiroga; Alberto Díaz Añel; Vivek Malhotra; Maria Paz Marzolo; Alfredo Cáceres
Journal:  J Neurosci       Date:  2008-09-10       Impact factor: 6.167

9.  In vitro cytotoxicity, pharmacokinetics, tissue distribution, and metabolism of small-molecule protein kinase D inhibitors, kb-NB142-70 and kb-NB165-09, in mice bearing human cancer xenografts.

Authors:  Jianxia Guo; Dana M Clausen; Jan H Beumer; Robert A Parise; Merrill J Egorin; Karla Bravo-Altamirano; Peter Wipf; Elizabeth R Sharlow; Qiming Jane Wang; Julie L Eiseman
Journal:  Cancer Chemother Pharmacol       Date:  2012-10-30       Impact factor: 3.333

10.  β-adrenergic signaling inhibits Gq-dependent protein kinase D activation by preventing protein kinase D translocation.

Authors:  C Blake Nichols; Chia-Wei Chang; Maura Ferrero; Brent M Wood; Matthew L Stein; Amanda J Ferguson; Derrick Ha; Robert R Rigor; Sven Bossuyt; Julie Bossuyt
Journal:  Circ Res       Date:  2014-03-18       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.